Alinity c Benzodiazepines Reagent Kit
Enzyme Immunoassay, Benzodiazepine. 510(k) K243498, from Microgenics Corporation (Fremont, CA). Product code JXM, class 2.
As of Nov 20, 2026, K243498 is an FDA 510(k) held by Microgenics Corporation, substantially equivalent on Dec 11, 2024 after 29 days, with no recalls tied to it in FDA's recall database.
- Review time: 29 days
- Recalls: 0
The Alinity c Benzodiazepines Reagent Kit is a homogeneous enzyme immunoassay intended for the qualitative and/or semiquantitative determination of the presence of benzodiazepines and their metabolites in human urine at a cutoff concentration of 200 ng/mL (0.700 μmol/L) on the Alinity c analyzer.
- DRI Benzodiazepine AssayK173963 · Microgenics Corporation · Feb 21, 2018
- ONLINE DAT Benzodiazepines IIK221765 · Roche Diagnostics · Dec 23, 2022
- Document
- 510(k) summary (PDF) ↗
- Type
- Special
- Received
- Nov 12, 2024
- Review panel
- Clinical Toxicology
- Regulation
- 21 CFR 862.3170
One page per 510(k), De Novo and original PMA. Recalls are those FDA's recall database ties to this number; recalls of related devices that cite another number are not shown. Refreshed weekly. Predicates are read by Arca from the text of FDA's 510(k) summary PDFs, most of them scans: a device number counts when the summary names it as a predicate or as the device it is substantially equivalent to. About 97% of those read were right on a sample we checked by hand; summaries from before 2000 often name predicates without a number, so older devices show fewer. Pivotal studies are read by a model from FDA's De Novo decision summaries and PMA SSEDs; a count or result is shown only when its numbers appear in FDA's text. openFDA device 510(k), PMA and recall files